Compton Capital Management Inc Abbott Laboratories Transaction History

Compton Capital Management Inc

  • $4.32 Billion
  • Q2 2023

A detailed history of Compton Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Compton Capital Management Inc holds 2,056 shares of ABT stock, worth $241,888. This represents 5.19% of its overall portfolio holdings.

Number of Shares
2,056
Previous 8,591 76.07%
Holding current value
$241,888
Previous $869,000 25693.44%
% of portfolio
5.19%
Previous 1.87%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
SELL
$100.78 - $112.29 $658,597 - $733,815
-6,535 Reduced 76.07%
2,056 $224 Million
Q1 2023

May 09, 2023
SELL
$96.86 - $114.01 $1.51 Million - $1.77 Million
-15,550 Reduced 64.41%
8,591 $869,000
Q4 2022

Feb 14, 2023
SELL
$95.06 - $111.52 $250,197 - $293,520
-2,632 Reduced 9.83%
24,141 $2.65 Million
Q3 2022

Nov 08, 2022
SELL
$96.76 - $112.03 $71,021 - $82,230
-734 Reduced 2.67%
26,773 $2.59 Million
Q2 2022

Aug 11, 2022
SELL
$102.07 - $123.37 $579,961 - $700,988
-5,682 Reduced 17.12%
27,507 $2.99 Million
Q1 2022

May 13, 2022
SELL
$114.02 - $139.04 $18,243 - $22,246
-160 Reduced 0.48%
33,189 $3.93 Million
Q3 2021

Nov 10, 2021
SELL
$116.66 - $129.06 $21,815 - $24,134
-187 Reduced 0.56%
33,349 $3.94 Million
Q2 2021

Aug 11, 2021
BUY
$105.79 - $124.53 $26,447 - $31,132
250 Added 0.75%
33,536 $3.89 Million
Q1 2021

May 04, 2021
SELL
$108.84 - $128.23 $31,563 - $37,186
-290 Reduced 0.86%
33,286 $3.99 Million
Q3 2020

Nov 12, 2020
SELL
$91.64 - $111.29 $73,312 - $89,032
-800 Reduced 2.33%
33,576 $3.65 Million
Q2 2020

Aug 12, 2020
SELL
$76.57 - $98.0 $1,531 - $1,960
-20 Reduced 0.06%
34,376 $3.14 Million
Q1 2020

May 06, 2020
SELL
$62.82 - $91.86 $19,097 - $27,925
-304 Reduced 0.88%
34,396 $2.71 Million
Q4 2019

Feb 10, 2020
SELL
$78.51 - $87.4 $7,851 - $8,740
-100 Reduced 0.29%
34,700 $3.01 Million
Q3 2019

Nov 07, 2019
SELL
$81.84 - $88.74 $45,012 - $48,807
-550 Reduced 1.56%
34,800 $2.91 Million
Q2 2019

Aug 13, 2019
SELL
$72.88 - $85.0 $7,288 - $8,500
-100 Reduced 0.28%
35,350 $2.97 Million
Q1 2019

May 14, 2019
SELL
$66.22 - $80.06 $21,521 - $26,019
-325 Reduced 0.91%
35,450 $2.83 Million
Q4 2018

Feb 13, 2019
SELL
$65.56 - $74.27 $41,696 - $47,235
-636 Reduced 1.75%
35,775 $2.59 Million
Q2 2018

Aug 14, 2018
SELL
$57.57 - $63.54 $1,496 - $1,652
-26 Reduced 0.07%
36,411 $2.22 Million
Q1 2018

May 11, 2018
SELL
$56.27 - $63.62 $5,627 - $6,362
-100 Reduced 0.27%
36,437 $2.18 Million
Q4 2017

Feb 14, 2018
SELL
$53.68 - $57.47 $16,104 - $17,241
-300 Reduced 0.81%
36,537 $2.09 Million
Q3 2017

Nov 14, 2017
SELL
$48.06 - $53.64 $35,131 - $39,210
-731 Reduced 1.95%
36,837 $1.97 Million
Q2 2017

Aug 14, 2017
BUY
N/A
37,568
37,568 $1.83 Million

Others Institutions Holding ABT

# of Institutions
3,173
Shares Held
1.33B
Call Options Held
8.62M
Put Options Held
7.18M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Compton Capital Management Inc Portfolio

Follow Compton Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Compton Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email